It was designed specifically to reduce visceral (belly) fat in people with conditions like HIV (3)
By targeting both the GIP and GLP-1 receptors, tirzepatide delivers complementary benefits, resulting in weight loss, which is essential for improving insulin sensitivity and overall metabolic health
Bile is good at doing that, but once its completed its job, it stays in the tract, reaching the far end of the intestine, where it stimulates GLP-1 secretion
Retatrutide is administered as a once-weekly subcutaneous injection, similar in delivery to other agents in this drug class
After that, the texture degrades, the color changes, and some nutrients begin to oxidize
Gene-gene interplay and gene-diet interactions involving the MTNR1B rs10830963 variant with body weight loss